Preview Mode Links will not work in preview mode

BrainWaves


Nov 23, 2017

This week on BrainWaves, we build on concepts introduced in episode 65 regarding the non-pharmacologic management of drug-resistant epilepsy. In the next two episodes, you'll hear from Dr. Danielle Becker (Penn) and Dr. Myriam Abdennadher (NIH) on the minimally invasive procedures that can drastically impact the lives of patients with refractory seizures.

Produced by James E. Siegler. Music by Steve Combs, Jason Shaw, and Josh Woodward. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision making.

REFERENCES

  1. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S and French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069-77.
  2. Nilsson L, Farahmand BY, Persson PG, Thiblin I and Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet. 1999;353:888-93.
  3. Tomson T, Nashef L and Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. The Lancet Neurology. 2008;7:1021-31.
  4. Willie JT, Laxpati NG, Drane DL, Gowda A, Appin C, Hao C, Brat DJ, Helmers SL, Saindane A, Nour SG and Gross RE. Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery. 2014;74:569-84; discussion 584-5.